Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer

BACKGROUND: Early detection of treatment failure may improve clinical outcome and overall survival in patients with head and neck cancer after first-line treatment. Circulating cell-free HPV16 DNA (cfHPV16 DNA) was evaluated as a possible complementary marker to radiological assessment of early resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutkowski, Tomasz W., Mazurek, Agnieszka M., Śnietura, Mirosław, Hejduk, Beata, Jędrzejewska, Maja, Bobek-Billewicz, Barbara, d’Amico, Andrea, Pigłowski, Wojciech, Wygoda, Andrzej, Składowski, Krzysztof, Kołosza, Zofia, Widłak, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158033/
https://www.ncbi.nlm.nih.gov/pubmed/32293457
http://dx.doi.org/10.1186/s12967-020-02330-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158033/
https://www.ncbi.nlm.nih.gov/pubmed/32293457
http://dx.doi.org/10.1186/s12967-020-02330-y

Ejemplares similares